China NMN (Nicotinamide mononucleotide) Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the NMN (Nicotinamide mononucleotide) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • EffePharm

    • Herbalmax

    • Bontac

    • Shinkowa Pharmaceutical

    • Shandong Sihuan Pharmaceutical Co,Ltd

    • Genex Formulas

    • GeneHarbor

    • Maac10 Formulas

    By Type:

    • Content Below 98%

    • Content Above 98%

    By Application:

    • Others

    • Cosmetics

    • Health care products

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China NMN (Nicotinamide mononucleotide) Market Overview 2018-2029

    • 1.1 China NMN (Nicotinamide mononucleotide) Industry Development Overview

    • 1.2 China NMN (Nicotinamide mononucleotide) Industry Development History

    • 1.3 China NMN (Nicotinamide mononucleotide) Industry Market Size (2018-2029)

    • 1.4 China NMN (Nicotinamide mononucleotide) Market Analysis by Type from Production Side

      • 1.4.1 China NMN (Nicotinamide mononucleotide) Production Volume, Production Value and Growth Rate of Content Below 98% (2018-2029)

      • 1.4.2 China NMN (Nicotinamide mononucleotide) Production Volume, Production Value and Growth Rate of Content Above 98% (2018-2029)

    • 1.5 China NMN (Nicotinamide mononucleotide) Market Analysis by Application from Consumption End

      • 1.5.1 China NMN (Nicotinamide mononucleotide) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China NMN (Nicotinamide mononucleotide) Sales Volume, Sales Value and Growth Rate of Cosmetics (2018-2029)

      • 1.5.3 China NMN (Nicotinamide mononucleotide) Sales Volume, Sales Value and Growth Rate of Health care products (2018-2029)

    • 1.6 China NMN (Nicotinamide mononucleotide) Market Analysis by Region

      • 1.6.1 North China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    Chapter 2 China NMN (Nicotinamide mononucleotide) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on NMN (Nicotinamide mononucleotide) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China NMN (Nicotinamide mononucleotide) Market Status and Competition Analysis in 2023

      • 2.2.3 China NMN (Nicotinamide mononucleotide) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China NMN (Nicotinamide mononucleotide) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on NMN (Nicotinamide mononucleotide) Industry Development

    Chapter 3 NMN (Nicotinamide mononucleotide)Industry Chain Analysis

    • 3.1 NMN (Nicotinamide mononucleotide) Industry Chain

    • 3.2 NMN (Nicotinamide mononucleotide) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the NMN (Nicotinamide mononucleotide) Market

    • 3.3 NMN (Nicotinamide mononucleotide) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the NMN (Nicotinamide mononucleotide) Market

    Chapter 4 China NMN (Nicotinamide mononucleotide) Market, by Type

    • 4.1 China NMN (Nicotinamide mononucleotide) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China NMN (Nicotinamide mononucleotide) Total Production Volume and Growth Rate from Production Side

    • 4.5 China NMN (Nicotinamide mononucleotide) Production Volume and Growth Rate, by Type

      • 4.5.1 China NMN (Nicotinamide mononucleotide) Production Volume and Growth Rate of Content Below 98%

      • 4.5.2 China NMN (Nicotinamide mononucleotide) Production Volume and Growth Rate of Content Above 98%

    Chapter 5 China NMN (Nicotinamide mononucleotide) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China NMN (Nicotinamide mononucleotide) Total Market Size and Growth Rate from Consumption End

    • 5.5 China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate, by Application

      • 5.5.1 China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate of Others

      • 5.5.2 China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate of Cosmetics

      • 5.5.3 China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate of Health care products

    Chapter 6 China NMN (Nicotinamide mononucleotide) Market, by Region

    • 6.1 China NMN (Nicotinamide mononucleotide) Production Volume and Production Value, by Region

    • 6.2 China NMN (Nicotinamide mononucleotide) Sales Volume and Sales Value, by Region

    Chapter 7 North China NMN (Nicotinamide mononucleotide) Market Analysis

    • 7.1 North China NMN (Nicotinamide mononucleotide) Market, by Type

    • 7.2 North China NMN (Nicotinamide mononucleotide) Market, by Application

    Chapter 8 Central China NMN (Nicotinamide mononucleotide) Market Analysis

    • 8.1 Central China NMN (Nicotinamide mononucleotide) Market, by Type

    • 8.2 Central China NMN (Nicotinamide mononucleotide) Market, by Application

    Chapter 9 South China NMN (Nicotinamide mononucleotide) Market Analysis

    • 9.1 South China NMN (Nicotinamide mononucleotide) Market, by Type

    • 9.2 South China NMN (Nicotinamide mononucleotide) Market, by Application

    Chapter 10 East China NMN (Nicotinamide mononucleotide) Market Analysis

    • 10.1 East China NMN (Nicotinamide mononucleotide) Market, by Type

    • 10.2 East China NMN (Nicotinamide mononucleotide) Market, by Application

    Chapter 11 Northeast China NMN (Nicotinamide mononucleotide) Market Analysis

    • 11.1 Northeast China NMN (Nicotinamide mononucleotide) Market, by Type

    • 11.2 Northeast China NMN (Nicotinamide mononucleotide) Market, by Application

    Chapter 12 Southwest China NMN (Nicotinamide mononucleotide) Market Analysis

    • 12.1 Southwest China NMN (Nicotinamide mononucleotide) Market, by Type

    • 12.2 Southwest China NMN (Nicotinamide mononucleotide) Market, by Application

    Chapter 13 Northwest China NMN (Nicotinamide mononucleotide) Market Analysis

    • 13.1 Northwest China NMN (Nicotinamide mononucleotide) Market, by Type

    • 13.2 Northwest China NMN (Nicotinamide mononucleotide) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 EffePharm

        • 14.1.1 EffePharm Company Profile

        • 14.1.2 EffePharm NMN (Nicotinamide mononucleotide) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Herbalmax

        • 14.2.1 Herbalmax Company Profile

        • 14.2.2 Herbalmax NMN (Nicotinamide mononucleotide) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bontac

        • 14.3.1 Bontac Company Profile

        • 14.3.2 Bontac NMN (Nicotinamide mononucleotide) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Shinkowa Pharmaceutical

        • 14.4.1 Shinkowa Pharmaceutical Company Profile

        • 14.4.2 Shinkowa Pharmaceutical NMN (Nicotinamide mononucleotide) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Shandong Sihuan Pharmaceutical Co,Ltd

        • 14.5.1 Shandong Sihuan Pharmaceutical Co,Ltd Company Profile

        • 14.5.2 Shandong Sihuan Pharmaceutical Co,Ltd NMN (Nicotinamide mononucleotide) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Genex Formulas

        • 14.6.1 Genex Formulas Company Profile

        • 14.6.2 Genex Formulas NMN (Nicotinamide mononucleotide) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 GeneHarbor

        • 14.7.1 GeneHarbor Company Profile

        • 14.7.2 GeneHarbor NMN (Nicotinamide mononucleotide) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Maac10 Formulas

        • 14.8.1 Maac10 Formulas Company Profile

        • 14.8.2 Maac10 Formulas NMN (Nicotinamide mononucleotide) Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 NMN (Nicotinamide mononucleotide) Industry Research Conclusions

    • 15.2 NMN (Nicotinamide mononucleotide) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China NMN (Nicotinamide mononucleotide) Industry Market Size (2018-2029)

    • Figure China NMN (Nicotinamide mononucleotide) Production Volume, Production Value and Growth Rate of Content Below 98% (2018-2029)

    • Figure China NMN (Nicotinamide mononucleotide) Production Volume, Production Value and Growth Rate of Content Above 98% (2018-2029)

    • Figure China NMN (Nicotinamide mononucleotide) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China NMN (Nicotinamide mononucleotide) Sales Volume, Sales Value and Growth Rate of Cosmetics (2018-2029)

    • Figure China NMN (Nicotinamide mononucleotide) Sales Volume, Sales Value and Growth Rate of Health care products (2018-2029)

    • Figure North China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    • Figure Central China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    • Figure South China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    • Figure East China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate from 2018-2029

    • Figure NMN (Nicotinamide mononucleotide) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China NMN (Nicotinamide mononucleotide) Market Share by Type in 2018

    • Figure China NMN (Nicotinamide mononucleotide) Market Share by Type in 2023

    • Figure China NMN (Nicotinamide mononucleotide) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Production Volume and Growth Rate of Content Below 98% (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Production Volume and Growth Rate of Content Above 98% (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Market Share by Application in 2018

    • Figure China NMN (Nicotinamide mononucleotide) Market Share by Application in 2023

    • Figure China NMN (Nicotinamide mononucleotide) Total Market Size and Growth Rate from Consumption End

    • Figure China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate of Others (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate of Cosmetics (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Market Size and Growth Rate of Health care products (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Production Volume by Region (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Production Volume Share by Region (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Production Volume Share by Region (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Production Value by Region (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Production Value Share by Region (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Production Value Share by Region (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Sales Volume by Region (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Sales Volume Share by Region (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Sales Volume Share by Region (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Sales Value by Region (2018-2023)

    • Table China NMN (Nicotinamide mononucleotide) Sales Value Share by Region (2018-2023)

    • Figure China NMN (Nicotinamide mononucleotide) Sales Value Share by Region (2018-2023)

    • Table North China NMN (Nicotinamide mononucleotide) Production Volume by Type (2018-2023)

    • Table North China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Figure North China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Table North China NMN (Nicotinamide mononucleotide) Sales Volume by Application (2018-2023)

    • Table North China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Figure North China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Table Central China NMN (Nicotinamide mononucleotide) Production Volume by Type (2018-2023)

    • Table Central China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Figure Central China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Table Central China NMN (Nicotinamide mononucleotide) Sales Volume by Application (2018-2023)

    • Table Central China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Figure Central China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Table South China NMN (Nicotinamide mononucleotide) Production Volume by Type (2018-2023)

    • Table South China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Figure South China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Table South China NMN (Nicotinamide mononucleotide) Sales Volume by Application (2018-2023)

    • Table South China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Figure South China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Table East China NMN (Nicotinamide mononucleotide) Production Volume by Type (2018-2023)

    • Table East China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Figure East China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Table East China NMN (Nicotinamide mononucleotide) Sales Volume by Application (2018-2023)

    • Table East China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Figure East China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Table Northeast China NMN (Nicotinamide mononucleotide) Production Volume by Type (2018-2023)

    • Table Northeast China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Figure Northeast China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Table Northeast China NMN (Nicotinamide mononucleotide) Sales Volume by Application (2018-2023)

    • Table Northeast China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Table Southwest China NMN (Nicotinamide mononucleotide) Production Volume by Type (2018-2023)

    • Table Southwest China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Figure Southwest China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Table Southwest China NMN (Nicotinamide mononucleotide) Sales Volume by Application (2018-2023)

    • Table Southwest China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Table Northwest China NMN (Nicotinamide mononucleotide) Production Volume by Type (2018-2023)

    • Table Northwest China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Figure Northwest China NMN (Nicotinamide mononucleotide) Production Volume Share by Type (2018-2023)

    • Table Northwest China NMN (Nicotinamide mononucleotide) Sales Volume by Application (2018-2023)

    • Table Northwest China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China NMN (Nicotinamide mononucleotide) Sales Volume Share by Application (2018-2023)

    • Table EffePharm Company Profile

    • Table EffePharm NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)

    • Table Herbalmax Company Profile

    • Table Herbalmax NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)

    • Table Bontac Company Profile

    • Table Bontac NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)

    • Table Shinkowa Pharmaceutical Company Profile

    • Table Shinkowa Pharmaceutical NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)

    • Table Shandong Sihuan Pharmaceutical Co,Ltd Company Profile

    • Table Shandong Sihuan Pharmaceutical Co,Ltd NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)

    • Table Genex Formulas Company Profile

    • Table Genex Formulas NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)

    • Table GeneHarbor Company Profile

    • Table GeneHarbor NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)

    • Table Maac10 Formulas Company Profile

    • Table Maac10 Formulas NMN (Nicotinamide mononucleotide) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.